WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY – Get Free Report)’s stock price rose 16.3% on Thursday. The stock traded as high as $25.9070 and last traded at $25.9070. 929 shares changed hands during mid-day trading, a decline of 82% from the average daily volume of 5,283 shares. The stock had previously closed at $22.28.
Wall Street Analysts Forecast Growth
Separately, Zacks Research raised shares of WuXi AppTec from a “hold” rating to a “strong-buy” rating in a research report on Tuesday. One investment analyst has rated the stock with a Strong Buy rating and one has given a Buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Strong Buy”.
Read Our Latest Research Report on WuXi AppTec
WuXi AppTec Trading Up 3.0%
The business’s fifty day simple moving average is $25.41 and its two-hundred day simple moving average is $19.36.
About WuXi AppTec
WuXi AppTec is a global pharmaceutical and biotechnology services company that provides contract research, development and manufacturing services. The company supports drug developers throughout the product life cycle, from early-stage discovery and laboratory testing through clinical development and commercial production.
Its offerings include medicinal and synthetic chemistry, biology research, preclinical and clinical testing, regulatory support, pharmaceutical manufacturing, and the development and manufacturing of advanced therapies.
See Also
- Five stocks we like better than WuXi AppTec
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
- South Korea’s Chip Exports Are Soaring—So Why Is This ETF Down 20%?
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
